Browsing Tag
Daphne Zohar
2 posts
Why Seaport’s U.S. IPO filing matters now for neuropsychiatric drug development and biotech capital markets
Seaport Therapeutics has filed for a U.S. IPO. Read how its neuropsychiatry pipeline could test biotech investor appetite in 2026.
PureTech Health acquires LYT-100 for lymphedema treatment
US biopharma company PureTech Health has acquired a clinical-stage product candidate called LYT-100, which will be developed as…